An NCI-designated Comprehensive Cancer Center
breakthroughs - betty ferrell headshot
Oncology nurse and palliative care expert reflects on 30 years at
City of Hope
January 15, 2020 | by Michael Easterling
In the nearly 42 years since she found her “calling,” Betty Ferrell, Ph.D., M.A., R.N., has established herself as a world-renowned expert on palliative and hospice care. She recently joined the National Academy of Medicine, one of the highest honors in health and medicine.
Patient Care
Ajay Goel
Aspirin appears to curb
colorectal cancer recurrence
January 13, 2020 | by Zen Vuong
The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and inhibit recurrence.
Research | Patient Care
Lung Cancer
Cancer death rate shows
steep decline in U.S.
January 9, 2020 | by Samantha Bonar
The cancer death rate in the United States showed its largest single-year drop ever reported, falling 2.2% from 2016 to 2017, according to the latest numbers from the American Cancer Society.
Donations increase as blood bank recruitment goes digital
January 9, 2020 | by Maxine Nunes
Thanks to a new blood donor digital recruitment strategy targeting millennials, donation appointments have increased 81% over last year. Although it’s a huge improvement, there are still not enough donors to provide City of Hope with all of the blood and platelets it needs.
Patient Care
Microbes in Space | City of Hope
Cancer care predictions 2020:
The best is yet to come
January 7, 2020 | by Abe Rosenberg
City of Hope clinicians and researchers are brimming with optimism as 2020 begins. Cancer care is changing rapidly, and the pace of change is accelerating. In 2020 look for major advances in gene-based therapy, immunotherapy and many other areas.
Research | Patient Care
Saul Priceman | City of Hope
What Is Immunotherapy?
January 2, 2020 | by Malcolm Bedell
Immunotherapy can be categorized into treatments that either stimulate an existing immune response to help it work harder to attack cancer cells, or by introducing additional immune system cells and proteins to “jump start” the immune system.